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By utilizing speciﬁc frequencies in the range of 6-30Hz based on tissue
type and grade of osteoarthritis this stimulus is recreated by SPMF therapy
leading to cartilage regeneration.
This recreated peizoelectric stimuli, is known to enhance mitosis and
cell regeneration by normalizing the abberant electromagnetic ﬁelds of
microtubules of the centrioles
Methods: 195 patients with bilateral osteoarthritis (OA) of knees were
assessed by internationally recognized Knee Society clinical rating system;
the scores computed prior to treatment, after 21 days of therapy, at 3 and
9 months. In addition, MRI of the treated knees was done using standard
protocol, before treatment, at three and nine months after treatment, to
measure objective changes in cartilage thickness.
Results: This non-randomized, phase II study showed statistically highly
signiﬁcant improvement in pain scores, total knee scores, total functional
scores and the range of motion, immediately after the treatment vis-à-vis
pre-treatment values, and this improvement persisted when re-evaluated
at three and nine months. There was also a signiﬁcant increase in cartilage
thickness at three months and nine months from 0.64mm (±0.02) baseline
to 0.88 mm (±0.07) in left knee, and 0.65mm (±0.02) to 0.89mm (±0.05)
in the right knee joint (p<0.001) at 3 months and to 1.26mm (±0.02mm)
in the left knee and 1.23mm (±0.03mm) in the right knee at the end of 9
months.
Conclusions: Therapeutic exposure to SPMF therapy is effective in ame-
liorating the signs and symptoms of OA, and inducing regeneration of
chondrocytes as evidenced by increase in cartilage thickness. SPMF therapy
is an effective treatment modality for osteoarthritis.
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Purpose: Articular cartilage lesions are an important problem in or-
thopaedic surgery. The use of progenitor cells such as bone marrow-derived
mesenchymal stem cells (MSCs), as platforms to deliver candidate genes
in a suitable conformation is an attractive approach to enhance cartilage
repair. Here, we tested the ability of rAAV vectors to overexpress FGF-2
that promotes the expansion and differentiation of human MSCs in a
three-dimensional environment.
Methods: rAAV were packaged, puriﬁed, and titrated as previously de-
scribed. All transgene cassettes were controlled by the CMV-IE pro-
moter/enhancer: E. coli beta-galactosidase (rAAV-lacZ), Red Fluorescent
Protein (rAAV-RFP), Fireﬂy luciferase (rAAV-luc), and a human basic ﬁbrob-
last growth factor (hFGF-2) cDNA (rAAV-hFGF-2). Bone marrow aspirates
were obtained from the iliac crest of donors. Aspirates were layered onto
Histopaque-1077 density gradient and the nucleated cell fraction was
collected and resuspended in hMSC culture medium containing stimulatory
supplements (StemCell Technologies Inc.). Cells were transduced with rAAV
for up to 21 days in monolayer or in aggregate cultures (2×105 cells). Ag-
gregates were kept in DMEM high glucose, ITS+ Premix, pyruvate, ascorbate
2-phosphate, dexamethasone, and TGF-β. Transgene expression was deter-
mined by X-Gal staining, live ﬂuorescence, luciferase assay, FGF-2 ELISA,
and by immunocyto- and immunohistochemistry. Paraﬃn-embedded sec-
tions of aggregates (5 μm) were stained with toluidine blue and alizarin
red. Indirect immunostaining was also performed to detect type-II and
type-X collagen, Runx-2, and Sox9. The DNA contents were monitored by
ﬂuorimetric assay, the proteoglycan contents by binding to DMMB, and
the type-II collagen contents by ELISA. Morphometric measurements were
performed at 3 standardized sites by image analysis. Each condition was
performed in triplicate in 2 independent experiments. Data are expressed
as mean ± SD. The t-test was employed with P<0.05 considered statistically
signiﬁcant.
Results: Sustained, dose-dependent transgene expression was observed in
monolayer cultures of hMSCs, with FGF-2 levels being from 350.2±2.5 to
41.1±1.2 pg/ml/24 h over time in rAAV-hFGF-2-transduced cells vis a vis
rAAV-lacZ (< 0.01 pg/ml/24 h). Luciferase activity was of 16.3±0.6 RLU/mg
total proteins after 21 days in rAAV-luc-transduced cells compared with
rAAV-lacZ (0.2±0.1 RLU/mg total proteins). Eﬃcient, sustained transgene
expression was also seen in aggregates (Fig. 1), with FGF-2 levels from
375.1±1.6 to 136.1±1.4 pg/ml/24 h over time in rAAV-hFGF-2 aggregates
Figure 1. Transgene expression in hMSCs aggregates (day 21).
Figure 2. Toluidine blue staining and detection of type-II collagen in hMSCs aggregates
(day 21).
vis a vis rAAV-lacZ (1.51±0.4 pg/ml/24 h). Chondrogenic differentiation of
cells was observed after 21 days in all types of aggregates (Fig. 2). Sox9
immunoreactivity was visible, whereas that for type-X collagen and Runx-2
and alizarin red staining were less intense. The diameters (856±30 versus
538±36 μm), DNA contents (1.039±0.005 versus 0.942±0.009 ng/mg total
proteins), and cell numbers (862±14 versus 435±12 cells/mm2) of the FGF-
2 aggregates were signiﬁcantly higher than those of the lacZ aggregates
(1.6-fold, 1.2-fold, and 1.9-fold, respectively; always P<0.001). In con-
trast, there was no difference in the proteoglycan contents (0.80±0.10 vs.
0.77±0.05 ng/mg total proteins) and type-II collagen contents (0.023±0.005
vs. 0.020±0.010 ng/mg total proteins) between both types of aggregates
(always P=1).
Conclusions: The data show that FGF-2 can be overexpressed in MSCs
via rAAV, promoting expansion and differentiation in a three-dimensional
environment, suggesting that gene modiﬁcation of MSCs via rAAV may ﬁna
application to treat articular cartilage lesions.
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Purpose: The aim of the study is to better understand the induction and
remodelling of cartilage-like tissue in non-woven ﬁlamentous scaffolds
intended for cartilage repair. The two objectives were to: 1) investigate the
effect of cumulative mechanical stimulus on cell proliferation, morphology
and metabolic activity in human bone marrow mesenchymal stem cells
(BMMSCs). These cells were seeded onto non-woven pads of biomaterial
and pulsatile hydrostatic pressure (PHP) applied incrementally over a 10
week period in a manner that simulates the loading conditions occurring at
a cartilage repair site after the implantation of scaffolds for cartilage repair,
and 2) thereby obtain an optimal post-operative rehabilitation regime
following joint implant surgery.
Methods: Human BMMSCs (Lonza) from 3 donors were seeded onto
226 plasma treated polyester scaffolds (PTPS) at 2.5×105 cells/scaffold
and divided into 2 groups; group one being subjected to PHP, group
two remained unloaded and acted as control. In group one, cell-seeded
